chrY-12303131-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000651802.1(ENSG00000291034):​n.451-61723C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.026 ( 0 hom., 871 hem., cov: 0)

Consequence

ENSG00000291034
ENST00000651802.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0640

Publications

1 publications found
Variant links:
Genes affected

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000651802.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0511 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000651802.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000291034
ENST00000651802.1
n.451-61723C>T
intron
N/A
ENSG00000291034
ENST00000651835.1
n.320-45100C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0264
AC:
868
AN:
32902
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00512
Gnomad AMI
AF:
0.148
Gnomad AMR
AF:
0.0577
Gnomad ASJ
AF:
0.0798
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0306
Gnomad FIN
AF:
0.000297
Gnomad MID
AF:
0.203
Gnomad NFE
AF:
0.0337
Gnomad OTH
AF:
0.0375
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0264
AC:
871
AN:
32967
Hom.:
0
Cov.:
0
AF XY:
0.0264
AC XY:
871
AN XY:
32967
show subpopulations
African (AFR)
AF:
0.00509
AC:
43
AN:
8448
American (AMR)
AF:
0.0576
AC:
205
AN:
3559
Ashkenazi Jewish (ASJ)
AF:
0.0798
AC:
61
AN:
764
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1237
South Asian (SAS)
AF:
0.0312
AC:
44
AN:
1410
European-Finnish (FIN)
AF:
0.000297
AC:
1
AN:
3364
Middle Eastern (MID)
AF:
0.206
AC:
14
AN:
68
European-Non Finnish (NFE)
AF:
0.0338
AC:
455
AN:
13452
Other (OTH)
AF:
0.0373
AC:
17
AN:
456

Age Distribution

Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
1.4
PhyloP100
0.064

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs9786460;
hg19: chrY-14423856;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.